MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5201.87M
Enterprise Value 3135.44M
Trailing P/E N/A
Forward P/E 1-4.02
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.37
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-3.19

Trading Information

Stock Price History

Beta (3Y Monthly) 4.31
52-Week Change 3-48.09%
S&P500 52-Week Change 37.14%
52 Week High 310.5400
52 Week Low 32.3600
50-Day Moving Average 34.3266
200-Day Moving Average 33.9150

Share Statistics

Avg Vol (3 month) 3526.24k
Avg Vol (10 day) 3460.37k
Shares Outstanding 540.52M
Float 44.02M
% Held by Insiders 10.92%
% Held by Institutions 172.27%
Shares Short (Jun 14, 2019) 43.9M
Short Ratio (Jun 14, 2019) 48.89
Short % of Float (Jun 14, 2019) 47.50%
Short % of Shares Outstanding (Jun 14, 2019) 47.43%
Shares Short (prior month May 15, 2019) 44.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-43.42%
Return on Equity (ttm)-77.95%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -42.47M
Net Income Avi to Common (ttm)-43.21M
Diluted EPS (ttm)-0.9840
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)60.85M
Total Cash Per Share (mrq)1.16
Total Debt (mrq)3.41M
Total Debt/Equity (mrq)5.91
Current Ratio (mrq)9.42
Book Value Per Share (mrq)1.10

Cash Flow Statement

Operating Cash Flow (ttm)-33.36M
Levered Free Cash Flow (ttm)-16.86M